imiquimod has been researched along with Libman-Sacks Disease in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 9 (45.00) | 24.3611 |
2020's | 10 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dou, H; Hou, Y; Kong, W; Li, D; Li, J; Liang, J; Lu, L; Pan, Y; Wang, J; Wang, T; Xia, X | 1 |
Fujishiro, M; Hayakawa, K; Ikeda, K; Kataoka, Y; Morimoto, S; Nishi, T; Sakuma, S; Sekigawa, I; Takamori, K; Yoshida, Y | 1 |
Horiba, N; Kato, A; Kito, A; Murai, A; Nishihara, K; Oyama, S; Yamazaki, M | 1 |
Chang, YH; Chen, HY; Chuang, JH; Li, FA; Li, SC; Lin, TK; Liou, CW; Shen, FC; Sheu, JJ; Su, YJ; Wang, PW; Weng, SW | 1 |
Akizuki, S; Hashimoto, M; Hiwa, R; Katsushima, M; Kitagori, K; Morinobu, A; Murakami, K; Nakashima, R; Nishida, Y; Onishi, A; Onizawa, H; Shirakashi, M; Takase, Y; Tanaka, M; Tsuji, H; Tsuruyama, T; Yoshifuji, H | 1 |
Barbarot, S; Giraud, S; Kervarrec, T; Laghmari, O; Leducq, S; Samimi, M | 1 |
Duarte, J; Gómez-Guzmán, M; Jiménez, R; O'valle, F; Robles-Vera, I; Romero, M; Sánchez, M; Toral, M; Visitación, N | 1 |
Blanco, LP; Carmona-Rivera, C; Goel, RR; Gupta, S; Hasneen, K; Kaplan, MJ; Kopp, JB; Kotenko, SV; Morasso, MI; Nakabo, S; O'Neil, LJ; Wang, X; Wigerblad, G; Yu, ZX | 1 |
Dou, H; Hou, Y; Jiang, Q; Li, D; Li, J; Pan, Y; Xia, X | 1 |
Choueiry, M; Fares, N; Hajal, J; Maalouly, G; Nassereddine, H; Noujeim, C; Saliba, Y; Smayra, V | 1 |
Fan, H; Hou, Y; Ji, J; Li, X; Liu, F; Xu, J; Yue, H; Zhao, S | 1 |
Elkon, KB; Sontheimer, C | 1 |
Fujimoto, C; Kamijima, R; Kataoka, S; Nakajima, K; Sano, S; Takaishi, M; Terada, Y; Yokogawa, M | 1 |
Dong, G; Fan, H; Hou, Y; Huang, Y; Ji, J; Liu, F; Ren, D; You, M | 1 |
Barrat, FJ; Elkon, KB; Fitzgerald, KA | 1 |
Chen, DP; Lam, CW; Li, EK; Tam, LS; Wong, CK; Wong, PT | 1 |
Chan, MP; Zimarowski, MJ | 1 |
CostaPinto, L; Grassi, MF; Olavarria, VN; Santiago, MB; Serravalle, K; Travessa, AC | 1 |
Alexopoulou, L; Demaria, O; Desnues, B | 1 |
Bolland, S; Deane, JA; Difilippantonio, MJ; Pisitkun, P; Satterthwaite, AB; Tarasenko, T | 1 |
1 review(s) available for imiquimod and Libman-Sacks Disease
Article | Year |
---|---|
Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Autoimmunity; Cytosol; DNA, Viral; Endosomes; Humans; Imiquimod; Immunity, Innate; Inflammation; Lupus Erythematosus, Systemic; Nucleic Acids; Psoriasis; Signal Transduction; Toll-Like Receptors; Virus Diseases | 2016 |
19 other study(ies) available for imiquimod and Libman-Sacks Disease
Article | Year |
---|---|
C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1
Topics: Adoptive Transfer; Adult; Animals; Apoptosis; Cell Differentiation; Cell Nucleus; Disease Models, Animal; Female; Forkhead Box Protein O1; Gene Expression Regulation; Gene Silencing; Humans; Imiquimod; Lectins, C-Type; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred C57BL; Middle Aged; Monocytes; Myeloid-Derived Suppressor Cells; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Receptors, Immunologic; Scavenger Receptors, Class E; Syk Kinase; Terpenes | 2021 |
Exposure of female NZBWF1 mice to imiquimod-induced lupus nephritis at an early age via a unique mechanism that differed from spontaneous onset.
Topics: Animals; Autoimmunity; Female; Imiquimod; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mice; Signal Transduction; Toll-Like Receptor 7 | 2022 |
Class II lupus nephritis with podocyte injury in imiquimod-induced lupus-prone mice.
Topics: Animals; Complement C1q; Female; Imiquimod; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Podocytes; Toll-Like Receptor 7 | 2022 |
A Study on MDA5 Signaling in Splenic B Cells from an Imiquimod-Induced Lupus Mouse Model with Proteomics.
Topics: Animals; DEAD-box RNA Helicases; Disease Models, Animal; Imiquimod; Interferon-Induced Helicase, IFIH1; Lupus Erythematosus, Systemic; Mice; Proteomics; Signal Transduction; Toll-Like Receptor 7; Virus Diseases | 2022 |
Enteric Toll-like receptor 7 stimulation causes acute exacerbation in lupus-susceptible mice.
Topics: Animals; Dendritic Cells; Imiquimod; Immunoglobulin G; Lupus Erythematosus, Systemic; Mice; Splenomegaly; Toll-Like Receptor 7 | 2023 |
Spectrum of imiquimod-induced lupus-like reactions: Report of two cases.
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Imiquimod; Lupus Erythematosus, Systemic | 2020 |
Toll-like receptor 7-driven lupus autoimmunity induces hypertension and vascular alterations in mice.
Topics: Acetophenones; Animals; Antioxidants; Autoantibodies; Autoimmunity; Blood Pressure; Blood Pressure Determination; Cyclic N-Oxides; Female; Hypertension; Imiquimod; Interleukin-17; Lupus Erythematosus, Systemic; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Spin Labels; T-Lymphocytes, Regulatory; Toll-Like Receptor 7; Vascular Diseases | 2020 |
Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus.
Topics: Animals; B-Lymphocytes; Cell Line; Gene Deletion; Humans; Imiquimod; Inflammation; Interferon Inducers; Interferon Lambda; Interferon Type I; Interferons; Keratinocytes; Lupus Erythematosus, Systemic; Mesangial Cells; Mice, Inbred C57BL; Mice, Mutant Strains; Receptors, Interferon; Signal Transduction; Toll-Like Receptor 7 | 2020 |
Urokinase-type plasminogen activator receptor is required for impairing toll-like receptor 7 signaling on macrophage efferocytosis in lupus.
Topics: Animals; Female; Humans; Imiquimod; Jurkat Cells; Lupus Erythematosus, Systemic; Macrophages, Peritoneal; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Peptides; Phagocytosis; RAW 264.7 Cells; Receptors, Urokinase Plasminogen Activator; Signal Transduction; Toll-Like Receptor 7; Up-Regulation | 2020 |
New insights in gut-liver axis in wild-type murine imiquimod-induced lupus.
Topics: Animals; Feces; Female; Imiquimod; Inflammation; Leukocyte L1 Antigen Complex; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; NF-kappa B; Tight Junctions; Toll-Like Receptor 4 | 2021 |
Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus.
Topics: Adolescent; Adult; Aminoquinolines; Animals; Antigens, CD1d; B-Lymphocytes; B7-2 Antigen; Blotting, Western; Female; Flow Cytometry; Humans; Imiquimod; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Spleen; Toll-Like Receptor 7; Young Adult | 2017 |
Editorial: toll-like receptor 7: more than skin deep?
Topics: Aminoquinolines; Animals; Autoimmunity; Imidazoles; Imiquimod; Lupus Erythematosus, Systemic; Toll-Like Receptor 7 | 2014 |
Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Autoantibodies; Autoimmunity; Disease Models, Animal; Imidazoles; Imiquimod; Lupus Erythematosus, Systemic; Mice; Skin; Spleen; Toll-Like Receptor 7 | 2014 |
Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.
Topics: Adult; Aminoquinolines; Animals; Antigens, CD19; B-Lymphocytes; Cluster Analysis; Cyclin D3; Disease Models, Animal; Down-Regulation; Female; Gene Expression Profiling; Gene Ontology; Gene Regulatory Networks; Humans; Imiquimod; Lupus Erythematosus, Systemic; Mice, Inbred C57BL; MicroRNAs; Protein Interaction Maps; RNA, Messenger; Toll-Like Receptor 7; Up-Regulation | 2016 |
Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
Topics: Adult; Aminoquinolines; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemokines; Dinucleoside Phosphates; Female; Flagellin; Humans; Imiquimod; Immunity, Innate; Interferon Inducers; Interleukins; Leukocytes, Mononuclear; Lipopolysaccharides; Lupus Erythematosus, Systemic; Middle Aged; Monocytes; Peptidoglycan; Poly I-C; RNA; Severity of Illness Index; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Lupus erythematosus-like reaction in imiquimod-treated skin: a report of 2 cases.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Dermatitis; Diagnosis, Differential; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis, Actinic; Lupus Erythematosus, Systemic; Male; Skin Neoplasms | 2011 |
Giant disseminated condylomatosis in SLE.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Papillomaviridae; Podophyllin; Treatment Outcome; Trichloroacetic Acid | 2012 |
[Toll-like receptor 8: the awkward TLR].
Topics: Adaptive Immunity; Aminoquinolines; Animals; Autoimmune Diseases; Clinical Trials, Phase I as Topic; Cytokines; Drug Evaluation, Preclinical; Gene Expression Regulation; Imiquimod; Immunity, Innate; Ligands; Lupus Erythematosus, Systemic; Membrane Glycoproteins; Mice; Models, Immunological; Neoplasms; RNA, Viral; Signal Transduction; Species Specificity; Toll-Like Receptor 3; Toll-Like Receptor 7; Toll-Like Receptor 8; Virus Diseases | 2012 |
Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication.
Topics: Agammaglobulinaemia Tyrosine Kinase; Aminoquinolines; Animals; Antibodies, Antinuclear; Antibody Specificity; Autoimmunity; B-Lymphocytes; Cell Nucleolus; Female; Gene Dosage; Gene Duplication; Imiquimod; In Situ Hybridization, Fluorescence; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Oligonucleotide Array Sequence Analysis; Protein-Tyrosine Kinases; Receptors, Antigen, B-Cell; RNA; Toll-Like Receptor 7; X Chromosome; Y Chromosome | 2006 |